A qualitative study exploring the experience and value of flow Transcranial Direct Current Stimulation (tDCS) and behaviour therapy training software used at home for Community Mental Health Team (CMHT) patients with symptoms of depression

Abstract

Background: Flow FL-100 is a self-administered transcranial direct current stimulation (tDCS) device with evidence of effectiveness in treating symptoms of depression. The Flow intervention also provides access to software application delivered wellbeing behaviour therapy training. Flow was offered by a community mental health team (CMHT) to those who experienced depressive symptoms. Participants completed six weeks use of Flow. This study explored participants’ experiences and views on feasibility, acceptability, useability, and value of Flow. Methods: A qualitative methodological approach was employed, involving in-depth semi-structured interviews. Interpretative Phenomenological Analysis (IPA) was applied. Out of a sample of 27 participants using Flow, 14 participants, seven females and seven males consented to be interviewed. The age range was 21 - 63 years (M = 40.21, SD = 13.99). Results: There was support for the feasibility, acceptability, useability and value of Flow. Most participants used Flow as per standard protocol and described a positive impact on depressive symptoms, mood, motivation, and functioning. Conclusion: Flow has been successfully integrated into a CMHT depression treatment. It is important to offer CMHT patients an evidenced-backed alternative to existing depression treatments (anti-depressant medication and psychotherapies). The results support the use of Flow as a treatment option for CMHT patients with symptoms of depression.